Pediatric Psychopharmacology : Principles and Practice

Foreword Steven Hyman
Preface
Section I Biological Bases of Pediatric Psychopharmacology
Subsection I-A: Developmental Principles of Neurobiology and Psychopharmacology
1. Overview of Brain Development, Flora M. Vaccarino and James F. Leckman
2. Synaptic Function and Biochemical Neuroanatomy, Stephan Heckers and Christine Konradi
3. Mechanisms of Signal Transduction and Adaptation to Psychotropic Drug Action, Lara M. Tolbert, Carrol D'Sa, and Ronald S. Duman
4. Pharmacokinetics I: Developmental Principles, Alexander A. Vinks and Philip D. Walson
5. Pharmacokinetics II: Cytochrome P450-Mediated Interactions, Jessica R. Oesterheld and David A. Flockhart
Subsection 1-B: Genetic Principles
6. Molecular Genetics, Surojit Paul and Paul J. Lombroso
7. Pharmacogenetics, George M. Anderson, Jeremy Veenstra-Vander Weele, Edwin H. Cook
Subsection I-C: Developmental Psychopathology
8. Neurobiology of Attention Regulation and its Disorders, Amy F.T. Arnsten and Francisco X. Castellanos
9. Neurobiology of Early-Life Stress and its Disorders, Christine Heim and Charles B. Nemeroof
10. Neurobiology of Early-Onset Mood Disorders, Joan Kaufman and Hilary Blumberg
11. Neurobiology of Early-Onset Anxiety Disorders, Vivian H. Koda, Dennis S. Charney and Daniel S. Pine
12. Neurobiology of Obsessive-Compulsive Disorder, Tanya K. Murphy, Kytja K.S. Voeller, and Pierre Blier
13. Neurobiology of Tic Disorders, Including Tourette's Syndrome, James F. Leckman, Chin-Bin Yeh, and Paul J. Lombroso
14. Neurobiology of Immune-Mediated Neuropsychiatric Disorders, Mary Lynn Dell, Charlotte S. Hamilton, and Susan E. Swedo
15. Neurobiology of Childhood Schizophrenia and Related Disorders, Rob Nicolson and Judith L. Rapoport
16. Neurobiology of Affiliation: Implications for Autism-Spectrum Disorders, Sherie Novotny, Martin Evers, Katherine Barboza, Ron Rawitt, and Eric Hollander
17. Neurobiology of Aggression, Marcus J.P. Kruesi, Sondra Keller, and Mark W. Wagner
18. Neurobiology of Eating Disorders, Walter Kaye, Michael Strober, Kelly L. Klump
19. Neurobiology of Substance Abuse Disorders, Leslie K. Jacobsen
SECTION II: SOMATIC INTERVENTIONS
Subsection II-A: Psychotropic Agents
20. Stimulants, Rebecca E. Ford, Laurence Greenhill, and Kelly Posner
21. Andrenergic Agonists: Chlonidine and Guanfacine, Jeffrey H. Newcorn, Kurt P. Schulz, and Jeffrey M. Halperin
22. Antidepressants I: Selective Serotonin Reuptake Inhibitors, Sufen Chiu and Henrietta L. Leonard
23. Antidepressants II: Tricyclic Agents, Karl Gundersen and Barbara Geller
24. Antidepressants III: Other Agents, John T. Walkup, Julia Ritter-Welzant, Elizabeth Kastelic, and Emily Frosh
25. Mood Stabilizers: Lithium, Anticonvulsants and Others, Pablo Davanzo and James McCracken
26. Antipyschotic Agents: Traditional and Atypical, Robert L. Findling, Nora K. McNamara, and Barbara L. Gracious
27. Anxiolytics: Benzodiazepines, Buspirone, and Others, Shannon R. Barnett and Mark A. Riddle
28. Miscellaneous Compounds: Beta-Blockers, Opiate Antagonists, and Others, Jan K. Buitelaar
Subsection II B. Other Somatic Interventions
29. Complementary and Alternative Medicine in Pediatric Psychopharmacology, Joseph M. Rey, Garry Walter, and Joseph P. Horrigan
30. Electroconvulsive Therapy(ECT) and Transcranial Magnetic Stimulation(TMS), Garry Walter, Joseph M. Rey, and Neera Ghaziuddin
SECTION III: ASSESSMENT AND TREATMENT
Subsection III-A: General Principles
31. Clinical Assessment of Children and Adolescents Treated Pharmacologically, Robert L. Hendren and Stephanie Hamarman
32. Clinical Instruments and Scales in Pediatric Psychpharmacology, L. Eugene Arnold and Michael G. Aman
33. Thinking About Prescribing: The Psychology of Psychopharmacology, Kyle D. Pruett
34. Combining Pharmacotherapy and Psychotherapy: An Evidence-Based Approach, John S. March and Karen Wells
Subsection III-B: Specific Disorders and Syndromes
35. Attention-Deficit Hyperactivity Disorder, Thomas Spencer, Joseph Biederman, Timothy Wilen, and oss Greene
36. Depression Disorder, Boris Birmaher and David Brent
37. Bipolar Disorder, Gabrielle A. Carlson
38. Anxiety Disorders, Michael J. Labellarte and Golda S. Ginsburg
39. Obsessive Compulsive Disorder, Daniel A. Geller and Thomas Spencer
40. Tourette's Syndrome and Other Tic Disorders, Robert A. King, Lawrence Scahill, Paul Lombroso, and James Leckman
41. Early-Onset Schizophrenia, Helmut Remschmidt and Johannes Hebebrand
42. Autistic and Other Pervasive Developmental Disorders, Christopher J. McDougle and David J. Posey
43. Post-Traumatic Stress Disorder, Craig L. Donnelly
44. Eating Disorders, Katherine A. Halmi
Subsection III-C: Special Clinical Populations
45. Substance Abusing Youths, James G. Waxmonsky and Timothy Wilens
46. Individuals with Mental Retardation, Michael G. Aman, Ronald L. Lindsay, Patricia L. Nash, and L. Eugene Arnold
47. The Medically Ill CHild or Adolescent, Jonathan A. Slater
48. Psychopharmacology During Pregnancy: Infant Considerations, C. Neil Epperson and Elizabeth A. Walter
49. Psychopharmacological Treatment of Preschoolers, Samuel L. Judice and Linda C. Mayes
Subsection III-D: Other Areas of Clinical Concern
50. Agitation and Aggression, Jean A. Frazier
51. Elimination Disorders: Enuresis and Encopresis, William Reiner
SECTION IV: EPIDEMIOLOGICAL, RESEARCH, AND METHODOLOGICAL CONSIDERATIONS
52. Pediatric Psychopharmacoepidemiology: Who is Prescribing? And For Whom, How, and Why?, Peter S. Jensen, Aryeh Edelman, and Robin Nemeroff
53. Clinical Trials Methodology and Design Issues, Bennedetto Vitiello
54. Regulatory Issues, Thomas P. Laughren
55. Ethical Issues in Research, Kimberly Hoagwood
56. International Perspectives, Per Hove Thompsen and Hiroshi Kurita
Appendix: Pediatric Psychopharmacology at a Glance

Nyckelord: MEDICAL / Pharmacology MED071000